Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Boston Scientific
MedTech
Boston Scientific puts $1.5B into MiRus, option to buy its TAVR
Boston Scientific is making a major investment play into a private medtech with an option to snap up exclusive rights to its TAVR system.
Ben Adams
May 18, 2026 8:31am
Boston Scientific heart plug stands up to blood thinners at ACC
Mar 30, 2026 11:02am
Boston Scientific to snap up Penumbra in deal valued at $14.5B
Jan 15, 2026 8:12am
Boston Scientific snaps up Valencia to bolster urology offerings
Jan 12, 2026 9:05am
Boston Scientific claims EU approval for Farapoint PFA catheter
Dec 2, 2025 12:28pm
Acquisitive Boston Scientific sees growth rate ease in Q3
Oct 22, 2025 10:05am
